Biomaterials for Local, Controlled Drug Delivery to the Injured Spinal Cord

Anderson, 1997, Biodegradation and biocompatibility of PLA and PLGA microspheres., Adv. Drug Deliv. Rev., 28, 5, 10.1016/S0169-409X(97)00048-3

Anderson, 2016, Astrocyte scar formation aids central nervous system axon regeneration., Nature, 532, 195, 10.1038/nature17623

Annabi, 2010, Controlling the porosity and microarchitecture of hydrogels for tissue engineering., Tissue Eng. Part B Rev., 16, 371, 10.1089/ten.teb.2009.0639

Ashley, 2013, Hydrogel drug delivery system with predictable and tunable drug release and degradation rates., Proc. Natl. Acad. Sci. U.S.A., 110, 2318, 10.1073/pnas.1215498110

Assunção-Silva, 2015, Hydrogels and cell based therapies in spinal cord injury regeneration., Stem Cells Int., 2015, 10.1155/2015/948040

Aurand, 2012, Building biocompatible hydrogels for tissue engineering of the brain and spinal cord., J. Funct. Biomater., 3, 839, 10.3390/jfb3040839

Bartholdi, 1995, Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat., Brain Res., 672, 177, 10.1016/0006-8993(94)01410-J

Bastani, 2012, Reduced antioxidant defense and increased oxidative stress in spinal cord injured patients., Arch. Phys. Med. Rehabil., 93, 2223, 10.1016/j.apmr.2012.06.021

Baumann, 2010, Intrathecal delivery of a polymeric nanocomposite hydrogel after spinal cord injury., Biomaterials, 31, 7631, 10.1016/j.biomaterials.2010.07.004

Begley, 2004, Delivery of therapeutic agents to the central nervous system: the problems and the possibilities., Pharmacol. Ther., 104, 29, 10.1016/j.pharmthera.2004.08.001

Bellamkonda, 1995, Hydrogel-based three-dimensional matrix for neural cells., J. Biomed. Mater. Res., 29, 663, 10.1002/jbm.820290514

Bensaïd, 2003, A biodegradable fibrin scaffold for mesenchymal stem cell transplantation., Biomaterials, 24, 2497, 10.1016/S0142-9612(02)00618-X

Bernards, 2006, Effect of postinjury intravenous or intrathecal methylprednisolone on spinal cord excitatory amino-acid release, nitric oxide generation, PGE2 synthesis, and myeloperoxidase content in a pig model of acute spinal cord injury., Spinal Cord, 44, 594, 10.1038/sj.sc.3101891

Bertz, 2013, Encapsulation of proteins in hydrogel carrier systems for controlled drug delivery: influence of network structure and drug size on release rate., J. Biotechnol., 163, 243, 10.1016/j.jbiotec.2012.06.036

Borgens, 2000, Immediate recovery from spinal cord injury through molecular repair of nerve membranes with polyethylene glycol., FASEB J., 14, 27, 10.1096/fasebj.14.1.27

Bottros, 2014, Current perspectives on intrathecal drug delivery., J. Pain Res., 7, 615, 10.2147/JPR.S37591

Bowersox, 1996, Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain., J. Pharmacol. Exp. Ther., 279, 1243

Bracken, 1990, A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury., N. Engl. J. Med., 322, 1405, 10.1056/nejm199005173222001

Bradbury, 2011, Manipulating the glial scar: chondroitinase ABC as a therapy for spinal cord injury., Brain Res. Bull., 84, 306, 10.1016/j.brainresbull.2010.06.015

Braughler, 1987, Evaluation of an intensive methylprednisolone sodium succinate dosing regimen in experimental spinal cord injury., J. Neurosurg., 67, 102, 10.3171/jns.1987.67.1.0102

Budhian, 2007, Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content., Int. J. Pharm., 336, 367, 10.1016/j.ijpharm.2006.11.061

Burda, 2016, Astrocyte roles in traumatic brain injury., Exp. Neurol., 275, 305, 10.1016/j.expneurol.2015.03.020

Burdick, 2006, Stimulation of neurite outgrowth by neurotrophins delivered from degradable hydrogels., Biomaterials, 27, 452, 10.1016/j.biomaterials.2005.06.034

Bydon, 2014, The current role of steroids in acute spinal cord injury., World Neurosurg., 82, 848, 10.1016/j.wneu.2013.02.062

Caicco, 2013, Characterization of hyaluronan–methylcellulose hydrogels for cell delivery to the injured spinal cord., J. Biomed. Mater. Res. A, 1472, 10.1002/jbm.a.34454

Cardenas, 2006, Treatments for chronic pain in persons with spinal cord injury: a survey study., J. Spinal Cord Med., 29, 109, 10.1080/10790268.2006.11753864

Casha, 2012, Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury., Brain, 135, 1224, 10.1093/brain/aws072

Cerqueira, 2013, Microglia response and In vivo therapeutic potential of methylprednisolone-loaded dendrimer nanoparticles in spinal cord injury., Small, 9, 738, 10.1002/smll.201201888

Chen, 2012, The influence of fiber diameter of electrospun poly(lactic acid) on drug delivery., Fibers Polym., 13, 1120, 10.1007/s12221-012-1120-x

Cheng, 2007, Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug delivery., Biomaterials, 28, 869, 10.1016/j.biomaterials.2006.09.047

Chvatal, 2008, Spatial distribution and acute anti-inflammatory effects of Methylprednisolone after sustained local delivery to the contused spinal cord., Biomaterials, 29, 1967, 10.1016/j.biomaterials.2008.01.002

Corey, 2007, Aligned electrospun nanofibers specify the direction of dorsal root ganglia neurite growth., J. Biomed. Mater. Res. A, 636, 10.1002/jbm.a.31285

Costa, 2015, Tolerability and efficacy of erythropoietin (EPO) treatment in traumatic spinal cord injury: a preliminary randomized comparative trial vs. methylprednisolone (MP)., Neurol. Sci., 36, 1567, 10.1007/s10072-015-2182-5

Cregg, 2014, Functional regeneration beyond the glial scar., Exp. Neurol., 253, 197, 10.1016/j.expneurol.2013.12.024

Cullen, 2007, Strain rate-dependent induction of reactive astrogliosis and cell death in three-dimensional neuronal-astrocytic co-cultures., Brain Res., 1158, 103, 10.1016/j.brainres.2007.04.070

Danhier, 2012, PLGA-based nanoparticles: an overview of biomedical applications., J. Control. Release, 161, 505, 10.1016/j.jconrel.2012.01.043

David, 2015, Macrophage and microglial plasticity in the injured spinal cord., Neuroscience, 307, 311, 10.1016/j.neuroscience.2015.08.064

de Ruiter, 2008, Methods for in vitro characterization of multichannel nerve tubes., J. Biomed. Mater. Res. A, 643, 10.1002/jbm.a.31298

des Rieux, 2014, Vascular endothelial growth factor-loaded injectable hydrogel enhances plasticity in the injured spinal cord., J. Biomed. Mater. Res. A, 102, 2345, 10.1002/jbm.a.34915

DeVos, 2013, Direct intraventricular delivery of drugs to the rodent central nervous system., J. Vis. Exp., 75, 10.3791/50326

Downing, 2012, Drug-eluting microfibrous patches for the local delivery of rolipram in spinal cord repair., J. Control. Release, 161, 910, 10.1016/j.jconrel.2012.05.034

Elliott Donaghue, 2015, Controlled release of bioactive PDGF-AA from a hydrogel/nanoparticle composite., Acta Biomater., 25, 35, 10.1016/j.actbio.2015.08.002

Estrada, 2014, Long-lasting significant functional improvement in chronic severe spinal cord injury following scar resection and polyethylene glycol implantation., Neurobiol. Dis., 67, 165, 10.1016/j.nbd.2014.03.018

Fleming, 2006, The cellular inflammatory response in human spinal cords after injury., Brain, 129, 3249, 10.1093/brain/awl296

Freund, 2013, Tracking changes following spinal cord injury insights from neuroimaging., Neuroscientist, 19, 116, 10.1177/1073858412449192

Fumagalli, 2008, Single exposure to erythropoietin modulates nerve growth factor expression in the spinal cord following traumatic injury: comparison with methylprednisolone., Eur. J. Pharmacol., 578, 19, 10.1016/j.ejphar.2007.09.021

Garcia, 2016, Cytokine and growth factor activation In Vivo and In Vitro after spinal cord injury., Mediators Inflamm., 2016, 10.1155/2016/9476020

Gelain, 2011, Transplantation of nanostructured composite scaffolds results in the regeneration of chronically injured spinal cords., ACS Nano, 5, 227, 10.1021/nn102461w

Gensel, 2015, Macrophage activation and its role in repair and pathology after spinal cord injury., Brain Res., 1619, 1, 10.1016/j.brainres.2014.12.045

Gerndt, 1997, Consequences of high-dose steroid therapy for acute spinal cord injury., J. Trauma, 42, 279, 10.1097/00005373-199702000-00017

Ghasemi-Mobarakeh, 2008, Electrospun poly(ε-caprolactone)/gelatin nanofibrous scaffolds for nerve tissue engineering., Biomaterials, 29, 4532, 10.1016/j.biomaterials.2008.08.007

Göritz, 2011, A pericyte origin of spinal cord scar tissue., Science, 333, 238, 10.1126/science.1203165

Gros, 2010, Regeneration of long-tract axons through sites of spinal cord injury using templated agarose scaffolds., Biomaterials, 31, 6719, 10.1016/j.biomaterials.2010.04.035

Guizar-Sahagun, 1994, Development of post-traumatic cysts in the spinal cord of rats subjected to severe spinal cord contusion., Surg. Neurol., 41, 241, 10.1016/0090-3019(94)90131-7

Gupta, 2006, Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord., Biomaterials, 27, 2370, 10.1016/j.biomaterials.2005.11.015

Gwak, 2015, Multifunctional nanoparticles for gene delivery and spinal cord injury., J. Biomed. Mater. Res. A, 103, 3474, 10.1002/jbm.a.35489

Haan, 2015, Crosstalk between macrophages and astrocytes affects proliferation, reactive phenotype and inflammatory response, suggesting a role during reactive gliosis following spinal cord injury., J. Neuroinflammation, 12, 10.1186/s12974-015-0327-3

Hackett, 2016, Understanding the NG2 glial scar after spinal cord injury., Front. Neurol., 7, 10.3389/fneur.2016.00199

Hanisch, 2007, Microglia: active sensor and versatile effector cells in the normal and pathologic brain., Nat. Neurosci., 10, 1387, 10.1038/nn1997

Hausmann, 2003, Post-traumatic inflammation following spinal cord injury., Spinal Cord, 41, 369, 10.1038/sj.sc.3101483

He, 2009, Manufacture of PLGA multiple-channel conduits with precise hierarchical pore architectures and In Vitro/Vivo evaluation for spinal cord injury., Tissue Eng. Part C Methods, 15, 243, 10.1089/ten.tec.2008.0255

Hill, 2016, A view from the ending: axonal dieback and regeneration following SCI., Neurosci. Lett., 10.1016/j.neulet.2016.11.002

Hoare, 2008, Hydrogels in drug delivery: progress and challenges., Polymer, 49, 1993, 10.1016/j.polymer.2008.01.027

Hsu, 1990, Methylprednisolone in spinal cord injury: the possible mechanism of action., J. Neurotrauma, 7, 115, 10.1089/neu.1990.7.115

Hulsebosch, 2002, Recent advances in pathophysiology and treatment of spinal cord injury., Adv. Physiol. Educ., 26, 238, 10.1152/advan.00039.2002

Hurtado, 2011, Robust CNS regeneration after complete spinal cord transection using aligned poly-l-lactic acid microfibers., Biomaterials, 32, 6068, 10.1016/j.biomaterials.2011.05.006

Iaci, 2007, Chondroitin sulfate proteoglycans in spinal cord contusion injury and the effects of chondroitinase treatment., J. Neurotrauma, 24, 1743, 10.1089/neu.2007.0366

Ishii, 2001, Increase of oligodendrocyte progenitor cells after spinal cord injury., J. Neurosci. Res., 65, 500, 10.1002/jnr.1180

Jain, 2006, In situ gelling hydrogels for conformal repair of spinal cord defects, and local delivery of BDNF after spinal cord injury., Biomaterials, 27, 497, 10.1016/j.biomaterials.2005.07.008

Jain, 2000, An evaluation of intrathecal ziconotide for the treatment of chronic pain., Expert Opin. Investig. Drugs, 9, 2403, 10.1517/13543784.9.10.2403

Jimenez Hamann, 2005, Injectable intrathecal delivery system for localized administration of EGF and FGF-2 to the injured rat spinal cord., Exp. Neurol., 194, 106, 10.1016/j.expneurol.2005.01.030

Johnson, 2016, Electrospun fibers for drug delivery after spinal cord injury and the effects of drug incorporation on fiber properties., Cells Tissues Organs, 202, 116, 10.1159/000446621

Johnson, 2009, Controlled release of neurotrophin-3 from fibrin-based tissue engineering scaffolds enhances neural fiber sprouting following subacute spinal cord injury., Biotechnol. Bioeng., 104, 1207, 10.1002/bit.22476

Johnson, 2010, Fibrin-based tissue engineering scaffolds enhance neural fiber sprouting and delays the accumulation of reactive astrocytes at the lesion in a subacute model of spinal cord injury., J. Biomed. Mater. Res. A, 92, 152, 10.1002/jbm.a.32343

Kabu, 2015, Drug delivery, cell-based therapies, and tissue engineering approaches for spinal cord injury., J. Control. Release, 219, 141, 10.1016/j.jconrel.2015.08.060

Kamaly, 2016, Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release., Chem. Rev., 116, 2602, 10.1021/acs.chemrev.5b00346

Karimi-Abdolrezaee, 2012, Reactive astrogliosis after spinal cord injury–beneficial and detrimental effects., Mol. Neurobiol., 46, 251, 10.1007/s12035-012-8287-4

Khaing, 2014, Advanced biomaterials for repairing the nervous system: what can hydrogels do for the brain?, Mater. Today, 17, 332, 10.1016/j.mattod.2014.05.011

Kigerl, 2009, Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord., J. Neurosci., 29, 13435, 10.1523/JNEUROSCI.3257-09.2009

Kim, 2009, Nanoparticle-mediated local delivery of methylprednisolone after spinal cord injury., Biomaterials, 30, 2582, 10.1016/j.biomaterials.2008.12.077

Klapka, 2006, Collagen matrix in spinal cord injury., J. Neurotrauma, 23, 422, 10.1089/neu.2006.23.422

Kremer, 1994, Pore-size distributions of cationic polyacrylamide hydrogels varying in initial monomer concentration and cross-linker/monomer ratio., Macromolecules, 27, 2965, 10.1021/ma00089a012

Kreuter, 1995, Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)., Brain Res., 674, 171, 10.1016/0006-8993(95)00023-J

Krych, 2009, Relationship between scaffold channel diameter and number of regenerating axons in the transected rat spinal cord., Acta Biomater., 5, 2551, 10.1016/j.actbio.2009.03.021

Lawrence, 2009, The Nuclear Factor NF-κB pathway in inflammation., Cold Spring Harb. Perspect. Biol., 1, 10.1101/cshperspect.a001651

Lech, 2013, Macrophages and fibrosis: how resident and infiltrating mononuclear phagocytes orchestrate all phases of tissue injury and repair., Biochim. Biophys. Acta, 1832, 989, 10.1016/j.bbadis.2012.12.001

Lee, 2010, Sustained delivery of thermostabilized chABC enhances axonal sprouting and functional recovery after spinal cord injury., Proc. Natl. Acad. Sci. U.S.A., 107, 3340, 10.1073/pnas.0905437106

Lee, 2003, Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat., J. Neurotrauma, 20, 1017, 10.1089/089771503770195867

Lee, 2011, Electrospun nanofibrous materials for neural tissue engineering., Polymers, 3, 413, 10.3390/polym3010413

Levin, 1980, Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability., J. Med. Chem., 23, 682, 10.1021/jm00180a022

Leypold, 2008, The early evolution of spinal cord lesions on MR imaging following traumatic spinal cord injury., Am. J. Neuroradiol., 29, 1012, 10.3174/ajnr.A0962

Li, 2015, Fibrin gel as an injectable biodegradable scaffold and cell carrier for tissue engineering., Sci. World J., 2015, 10.1155/2015/685690

Liu, 2013, Current sustained delivery strategies for the design of local neurotrophic factors in treatment of neurological disorders., Asian J. Pharm. Sci., 8, 269, 10.1016/j.ajps.2013.10.003

Liu, , Nanofibrous collagen nerve conduits for spinal cord repair., Tissue Eng. Part A, 18, 1057, 10.1089/ten.tea.2011.0430

Liu, , Sustained release of neurotrophin-3 and chondroitinase ABC from electrospun collagen nanofiber scaffold for spinal cord injury repair., J. Biomed. Mater. Res. A, 100, 236, 10.1002/jbm.a.33271

Liu, 1997, Neuronal and glial apoptosis after traumatic spinal cord injury., J. Neurosci., 17, 5395, 10.1523/JNEUROSCI.17-14-05395.1997

Liu, 2008, Control of dimensional stability and degradation rate in electrospun composite scaffolds composed of poly(d,l-lactide-co-glycolide) and poly(ε-caprolactone)., Chin. J. Polym. Sci., 26, 63, 10.1142/S0256767908002674

Loh, 2001, The regrowth of axons within tissue defects in the CNS is promoted by implanted hydrogel matrices that contain BDNF and CNTF Producing Fibroblasts., Exp. Neurol., 170, 72, 10.1006/exnr.2001.7692

Loubser, 1996, Effects of intrathecal baclofen on chronic spinal cord injury pain., J. Pain Symptom Manage., 12, 241, 10.1016/0885-3924(96)00152-2

Luo, 2002, Polyethylene glycol immediately repairs neuronal membranes and inhibits free radical production after acute spinal cord injury., J. Neurochem., 83, 471, 10.1046/j.1471-4159.2002.01160.x

Lynam, 2015, Brain derived neurotrophic factor release from layer-by-layer coated agarose nerve guidance scaffolds., Acta Biomater., 18, 128, 10.1016/j.actbio.2015.02.014

Madigan, 2009, Current tissue engineering and novel therapeutic approaches to axonal regeneration following spinal cord injury using polymer scaffolds., Respir. Physiol. Neurobiol., 169, 183, 10.1016/j.resp.2009.08.015

Mantovani, 2004, The chemokine system in diverse forms of macrophage activation and polarization., Trends Immunol., 25, 677, 10.1016/j.it.2004.09.015

Marras-Marquez, 2014, Agarose drug delivery systems upgraded by surfactants inclusion: critical role of the pore architecture., Carbohydr. Polym., 103, 359, 10.1016/j.carbpol.2013.12.026

Masserini, 2013, Nanoparticles for brain drug delivery., ISRN Biochem., 2013, 10.1155/2013/238428

Mautes, 2000, Vascular events after spinal cord injury: contribution to secondary pathogenesis., Phys. Ther., 80, 673, 10.1093/ptj/80.7.673

McKay, 2014, Design of hydrogel biomaterial interfaces for the injured spinal cord., Surf. Innov., 2, 26, 10.1680/si.13.00016

McKay, 2014, An injectable, calcium responsive composite hydrogel for the treatment of acute spinal cord injury., ACS Appl. Mater. Interfaces, 6, 1424, 10.1021/am4027423

Meilander, 2001, Lipid-based microtubular drug delivery vehicles., J. Control. Release, 71, 141, 10.1016/S0168-3659(01)00214-0

Moore, 2006, Multiple-channel scaffolds to promote spinal cord axon regeneration., Biomaterials, 27, 419, 10.1016/j.biomaterials.2005.07.045

Mu, 2014, Progress of electrospun fibers as nerve conduits for neural tissue repair., Nanomedicine, 9, 1869, 10.2217/nnm.14.70

Nakielski, 2015, Experimental and numerical evaluation of drug release from nanofiber mats to brain tissue., J. Biomed. Mater. Res. B Appl. Biomater., 103, 282, 10.1002/jbm.b.33197

Natu, 2010, Effects of drug solubility, state and loading on controlled release in bicomponent electrospun fibers., Int. J. Pharm., 397, 50, 10.1016/j.ijpharm.2010.06.045

Natu, 2013, Influence of polymer processing technique on long term degradation of poly(ε-caprolactone) constructs., Polym. Degrad. Stab., 98, 44, 10.1016/j.polymdegradstab.2012.10.030

Neirinckx, 2014, Neutrophil contribution to spinal cord injury and repair., J. Neuroinflammation, 11, 10.1186/s12974-014-0150-2

Nguyen, 2010, Injectable biodegradable hydrogels., Macromol. Biosci., 10, 563, 10.1002/mabi.200900402

2016, Spinal Cord Injury (SCI) facts and figures at a glance., J. Spinal Cord Med., 39, 123, 10.1080/10790268.2016.1127042

Olson, 2009, Neural stem cell– and schwann cell–loaded biodegradable polymer scaffolds support axonal regeneration in the transected spinal cord., Tissue Eng. Part A, 15, 1797, 10.1089/ten.tea.2008.0364

Oyinbo, 2011, Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade., Acta Neurobiol. Exp. (Warsz.), 71, 281, 10.55782/ane-2011-1848

Pakulska, 2013, Affinity-based release of chondroitinase ABC from a modified methylcellulose hydrogel., J. Control. Release, 171, 11, 10.1016/j.jconrel.2013.06.029

Pakulska, 2015, Hybrid crosslinked methylcellulose hydrogel: a predictable and tunable platform for local drug delivery., Adv. Mater., 27, 5002, 10.1002/adma.201502767

Papa, 2014, Polymeric nanoparticle system to target activated microglia/macrophages in spinal cord injury., J. Control. Release, 174, 15, 10.1016/j.jconrel.2013.11.001

Pardridge, 2005, The blood-brain barrier: bottleneck in brain drug development., NeuroRx, 2, 3, 10.1602/neurorx.2.1.3

Park, 2004, The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration., J. Neurotrauma, 21, 754, 10.1089/0897715041269641

Park, 1995, Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition., Biomaterials, 16, 1123, 10.1016/0142-9612(95)93575-X

Patel, 2012, Polymeric nanoparticles for drug delivery to the central nervous system., Adv. Drug Deliv. Rev., 64, 701, 10.1016/j.addr.2011.12.006

Péan, 1998, NGF release from poly(d,l-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability., J. Control. Release, 56, 175, 10.1016/S0168-3659(98)00086-8

Penn, 1995, Catheter systems for intrathecal drug delivery., J. Neurosurg., 83, 215, 10.3171/jns.1995.83.2.0215

Peppas, 1999, Poly(ethylene glycol)-containing hydrogels in drug delivery., J. Control. Release, 62, 81, 10.1016/S0168-3659(99)00027-9

Plant, 1998, Implantation of collagen IV/poly(2-hydroxyethyl methacrylate) hydrogels containing Schwann cells into the lesioned rat optic tract., Cell Transplant., 7, 381, 10.1016/S0963-6897(98)00016-5

Plant, 1995, Axonal growth within poly (2-hydroxyethyl methacrylate) sponges infiltrated with Schwann cells and implanted into the lesioned rat optic tract., Brain Res., 671, 119, 10.1016/0006-8993(94)01312-6

Plant, 1997, Hydrogels containing peptide or aminosugar sequences implanted into the rat brain: influence on cellular migration and axonal growth., Exp. Neurol., 143, 287, 10.1006/exnr.1997.6407

Qian, 2004, High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients., Spinal Cord, 43, 199, 10.1038/sj.sc.3101681

Rabchevsky, 2011, Latest approaches for the treatment of spasticity and autonomic dysreflexia in chronic spinal cord injury., Neurotherapeutics, 8, 274, 10.1007/s13311-011-0025-5

Rabchevsky, 2011, Pharmacological interventions for spinal cord injury: where do we stand? How might we step forward?, Pharmacol. Ther., 132, 15, 10.1016/j.pharmthera.2011.05.001

Ren, 2014, Repair of spinal cord injury by inhibition of astrocyte growth and inflammatory factor synthesis through local delivery of flavopiridol in PLGA nanoparticles., Biomaterials, 35, 6585, 10.1016/j.biomaterials.2014.04.042

Reneker, 1996, Nanometre diameter fibres of polymer, produced by electrospinning., Nanotechnology, 7, 10.1088/0957-4484/7/3/009

Rivet, 2015, Cell infiltration into a 3D electrospun fiber and hydrogel hybrid scaffold implanted in the brain., Biomatter, 5, 10.1080/21592535.2015.1005527

Robel, 2011, The stem cell potential of glia: lessons from reactive gliosis., Nat. Rev. Neurosci., 12, 88, 10.1038/nrn2978

Rooney, 2011, Sustained delivery of dibutyryl cyclic adenosine monophosphate to the transected spinal cord via oligo [(polyethylene glycol) fumarate] hydrogels., Tissue Eng. Part A, 17, 1287, 10.1089/ten.tea.2010.0396

Sakiyama-Elbert, , Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix., J. Control. Release, 69, 149, 10.1016/S0168-3659(00)00296-0

Sakiyama-Elbert, , Development of fibrin derivatives for controlled release of heparin-binding growth factors., J. Control. Release, 65, 389, 10.1016/S0168-3659(99)00221-7

Schaub, 2011, Controlled release of 6-aminonicotinamide from aligned, electrospun fibers alters astrocyte metabolism and dorsal root ganglia neurite outgrowth., J. Neural Eng., 8, 10.1088/1741-2560/8/4/046026

Schaub, 2015, Electrospun fibers for spinal cord injury research and regeneration., J. Neurotrauma, 33, 1405, 10.1089/neu.2015.4165

Schnell, 2007, Guidance of glial cell migration and axonal growth on electrospun nanofibers of poly-ε-caprolactone and a collagen/poly-ε-caprolactone blend., Biomaterials, 28, 3012, 10.1016/j.biomaterials.2007.03.009

Schwab, 1996, Degeneration and regeneration of axons in the lesioned spinal cord., Physiol. Rev., 76, 319, 10.1152/physrev.1996.76.2.319

Seif, 2015, Overcoming drug crystallization in electrospun fibers – Elucidating key parameters and developing strategies for drug delivery., Int. J. Pharm., 478, 390, 10.1016/j.ijpharm.2014.11.045

Sekhon, 2001, Epidemiology, demographics, and pathophysiology of acute spinal cord injury., Spine, 26, S2, 10.1097/00007632-200112151-00002

Sharp, 2012, Salmon fibrin treatment of spinal cord injury promotes functional recovery and density of serotonergic innervation., Exp. Neurol., 235, 345, 10.1016/j.expneurol.2012.02.016

Shrestha, 2014, Repair of injured spinal cord using biomaterial scaffolds and stem cells., Stem Cell Res. Ther., 5, 10.1186/scrt480

Silver, 2004, Regeneration beyond the glial scar., Nat. Rev. Neurosci., 5, 146, 10.1038/nrn1326

Singh, 2012, Current therapeutic strategies for inflammation following traumatic spinal cord injury., Neural Regen. Res., 7, 1812, 10.3969/j.issn.1673-5374.2012.23.008

Sironi, 2006, Differential regulation of chemokine production by Fcγ receptor engagement in human monocytes: association of CCL1 with a distinct form of M2 monocyte activation (M2b, Type 2)., J. Leukoc. Biol., 80, 342, 10.1189/jlb.1005586

Skop, 2013, Heparin crosslinked chitosan microspheres for the delivery of neural stem cells and growth factors for central nervous system repair., Acta Biomater., 9, 6834, 10.1016/j.actbio.2013.02.043

Soderblom, 2013, Perivascular fibroblasts form the fibrotic scar after contusive spinal cord injury., J. Neurosci., 33, 13882, 10.1523/JNEUROSCI.2524-13.2013

Sofroniew, 2009, Molecular dissection of reactive astrogliosis and glial scar formation., Trends Neurosci., 32, 638, 10.1016/j.tins.2009.08.002

Sofroniew, 2010, Astrocytes: biology and pathology., Acta Neuropathol. (Berl.), 119, 7, 10.1007/s00401-009-0619-8

Stanwick, 2012, In vitro sustained release of bioactive anti-NogoA, a molecule in clinical development for treatment of spinal cord injury., Int. J. Pharm., 426, 284, 10.1016/j.ijpharm.2012.01.035

Stokols, 2006, Templated agarose scaffolds support linear axonal regeneration., Tissue Eng., 12, 2777, 10.1089/ten.2006.12.2777

Straley, 2010, Biomaterial design strategies for the treatment of spinal cord injuries., J. Neurotrauma, 27, 1, 10.1089/neu.2009.0948

Tam, 2014, Regenerative therapies for central nervous system diseases: a biomaterials approach., Neuropsychopharmacology, 39, 169, 10.1038/npp.2013.237

Taylor, 2004, Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury., J. Control. Release, 98, 281, 10.1016/j.jconrel.2004.05.003

Taylor, 2006, Delivery of neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injury., J. Control. Release, 113, 226, 10.1016/j.jconrel.2006.05.005

Taylor, 2006, Effect of controlled delivery of neurotrophin-3 from fibrin on spinal cord injury in a long term model., J. Control. Release, 116, 204, 10.1016/j.jconrel.2006.07.005

Teasell, 2010, A systematic review of pharmacological treatments of pain following spinal cord injury., Arch. Phys. Med. Rehabil., 91, 816, 10.1016/j.apmr.2010.01.022

Teng, 2004, Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury., Proc. Natl. Acad. Sci. U.S.A., 101, 3071, 10.1073/pnas.0306239101

Totoiu, 2005, Spinal cord injury is accompanied by chronic progressive demyelination., J. Comp. Neurol., 486, 373, 10.1002/cne.20517

Tyler, 2013, Nanomedicine for treating spinal cord injury., Nanoscale, 5, 8821, 10.1039/c3nr00957b

Upadhyay, 2014, Drug delivery systems, CNS protection, and the blood brain barrier., BioMed Res. Int, 2014, 10.1155/2014/869269

Urata, 1999, Modification of release rates of cyclosporin A from polyl(L-lactic acid) microspheres by fatty acid esters and in-vivo evaluation of the microspheres., J. Control. Release, 58, 133, 10.1016/S0168-3659(98)00146-1

Varghese, 2014, Gelatin–carrageenan hydrogels: role of pore size distribution on drug delivery process., Colloids Surf. B Biointerfaces, 113, 346, 10.1016/j.colsurfb.2013.08.049

Varma, 2013, Spinal cord injury: a review of current therapy, future treatments, and basic science frontiers., Neurochem. Res., 38, 895, 10.1007/s11064-013-0991-6

Vulic, 2012, Tunable growth factor delivery from injectable hydrogels for tissue engineering., J. Am. Chem. Soc., 134, 882, 10.1021/ja210638x

Wang, 2010, Varying the diameter of aligned electrospun fibers alters neurite outgrowth and Schwann cell migration., Acta Biomater., 6, 2970, 10.1016/j.actbio.2010.02.020

Wang, 2008, Sustained intraspinal delivery of neurotrophic factor encapsulated in biodegradable nanoparticles following contusive spinal cord injury., Biomaterials, 29, 4546, 10.1016/j.biomaterials.2008.07.050

Wanner, 2008, A new in vitro model of the glial scar inhibits axon growth., Glia, 56, 1691, 10.1002/glia.20721

Ward, 2014, A characterization of white matter pathology following spinal cord compression injury in the rat., Neuroscience, 260, 227, 10.1016/j.neuroscience.2013.12.024

Weidner, 1999, Elimination of basal lamina and the collagen “Scar” after spinal cord injury fails to augment corticospinal tract regeneration., Exp. Neurol., 160, 40, 10.1006/exnr.1999.7200

Wells, 2003, Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice., Brain, 126, 1628, 10.1093/brain/awg178

Wilems, 2015, Sustained dual drug delivery of anti-inhibitory molecules for treatment of spinal cord injury., J. Control. Release, 213, 103, 10.1016/j.jconrel.2015.06.031

Woerly, 1995, Intracerebral implantation of hydrogel-coupled adhesion peptides: tissue reaction., Neural Plast., 5, 245, 10.1155/NP.1994.245

Woerly, 1999, Neural tissue formation within porous hydrogels implanted in brain and spinal cord lesions: ultrastructural, immunohistochemical, and diffusion studies., Tissue Eng., 5, 467, 10.1089/ten.1999.5.467

Xia, 2013, Sustained delivery of dbcAMP by poly(propylene carbonate) micron fibers promotes axonal regenerative sprouting and functional recovery after spinal cord hemisection., Brain Res., 1538, 41, 10.1016/j.brainres.2013.09.027

Xie, 2015, Pharmacokinetics and bioavailability of a therapeutic enzyme (idursulfase) in cynomolgus monkeys after intrathecal and intravenous administration., PLoS ONE, 10, 10.1371/journal.pone.0122453

Xie, 2009, Neurite outgrowth on nanofiber scaffolds with different orders, structures, and surface properties., ACS Nano, 3, 1151, 10.1021/nn900070z

Xie, 2010, Electrospun nanofibers for neural tissue engineering., Nanoscale, 2, 35, 10.1039/B9NR00243J

Xie, 2010, Electrospun poly(D,L-lactide) fibers for drug delivery: the influence of cosolvent and the mechanism of drug release., J. Appl. Polym. Sci., 115, 1, 10.1002/app.31026

Xu, 1998, Methylprednisolone inhibition of TNF-α expression and NF-kB activation after spinal cord injury in rats., Mol. Brain Res., 59, 135, 10.1016/S0169-328X(98)00142-9

Yang, 2004, Characterization of neural stem cells on electrospun poly(L-lactic acid) nanofibrous scaffold., J. Biomater. Sci. Polym. Ed., 15, 1483, 10.1163/1568562042459733

Yang, 2009, Multiple channel bridges for spinal cord injury: cellular characterization of host response., Tissue Eng. Part A, 15, 3283, 10.1089/ten.tea.2009.0081

Yao, 2013, Improved axonal regeneration of transected spinal cord mediated by multichannel collagen conduits functionalized with neurotrophin-3 gene., Gene Ther., 20, 1149, 10.1038/gt.2013.42

Yazihan, 2008, Erythropoietin improves oxidative stress following spinal cord trauma in rats., Injury, 39, 1408, 10.1016/j.injury.2008.03.010

Yeo, 2004, Control of encapsulation efficiency and initial burst in polymeric microparticle systems., Arch. Pharm. Res., 27, 1, 10.1007/BF02980037

Zhang, 2012, Inflammation & apoptosis in spinal cord injury., Indian J. Med. Res., 135, 287

Zhou, 2014, Function of microglia and macrophages in secondary damage after spinal cord injury., Neural Regen. Res., 9, 1787, 10.4103/1673-5374.143423

Zuidema, 2015, Magnetic NGF-releasing PLLA/Iron oxide nanoparticles direct extending neurites and preferentially guide neurites along aligned electrospun microfibers., ACS Chem. Neurosci., 6, 1781, 10.1021/acschemneuro.5b00189

Zurita, 2001, Presence and significance of CD-95 (Fas/APO1) expression after spinal cord injury., J. Neurosurg., 94, 257, 10.3171/spi.2001.94.2.0257